Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting Multiple Sclerosis”

727 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 727 results

Large-scale testing (Phase 3)Study completedNCT00662649
What this trial is testing

Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Novartis 920
Large-scale testing (Phase 3)Not Yet RecruitingNCT07189325
What this trial is testing

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy
University Hospital, Montpellier 250
Post-approval studies (Phase 4)Study completedNCT02048072
What this trial is testing

Evaluation of the Autonomic Nervous System During First-dosing With 0.5mg of Fingolimod (Gilenya) in Patients With Relapsing-remitting MS

Who this might be right for
Multiple SclerosisAutonomic Nervous System Dysfunction
Jochen Vehoff 33
Not applicableLooking for participantsNCT06586177
What this trial is testing

Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Heinrich-Heine University, Duesseldorf 100
Post-approval studies (Phase 4)UnknownNCT04048577
What this trial is testing

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Berkovich, Regina MD, PhD Inc. 10
Not applicableStudy completedNCT04115930
What this trial is testing

Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients

Who this might be right for
Relapsing Remitting Multiple SclerosisFatigueQuality of Life+1 more
University of Eastern Finland 61
Post-approval studies (Phase 4)Study completedNCT03385356
What this trial is testing

Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingVitamin D Deficiency
University Medical Centre Maribor 89
Not applicableUnknownNCT03787446
What this trial is testing

PET Study in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of British Columbia 9
Testing effectiveness (Phase 2)Study completedNCT03381170
What this trial is testing

An Extension of the TG1101-RMS201 Trial

Who this might be right for
Relapsing Remitting Multiple Sclerosis
TG Therapeutics, Inc. 48
Not applicableStudy completedNCT01142492
What this trial is testing

A Postmarketing Surveillance (PMS) Study to Evaluate the Extent to Which Patient Compliance is Influenced by Use of a Variable Titration Regimen at the Start of Treatment of Relapsing Multiple Sclerosis (MS) With Interferon Beta 1a (Rebif®)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 403
Not applicableStudy completedNCT04832399
What this trial is testing

Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 60
Not applicableStudy completedNCT00594087
What this trial is testing

Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)

Who this might be right for
Relapsing Remitting Multiple SclerosisSleep Initiation and Maintenance DisordersFatigue
University of Vermont 30
Not applicableUnknownNCT05735067
What this trial is testing

The Impact of Body Weight on Clinical and Immunological Outcomes in Relapse-Remitting Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
German University in Cairo 138
Post-approval studies (Phase 4)Study completedNCT01767493
What this trial is testing

Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients

Who this might be right for
Multiple Sclerosis
Institute for Neurodegenerative Disorders 19
Not applicableUnknownNCT01250665
What this trial is testing

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisCognitive Impairment
Cantonal Hospital of St. Gallen 65
Post-approval studies (Phase 4)Study completedNCT01585298
What this trial is testing

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 6,998
Early research (Phase 1)Study completedNCT01738347
What this trial is testing

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Who this might be right for
Relapsing-remitting Multiple Sclerosis (rrMS)
GE Healthcare 30
Testing effectiveness (Phase 2)Study completedNCT01717664
What this trial is testing

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing Remitting Multiple Sclerosis
RedHill Biopharma Limited 18
Very early researchStudy completedNCT03498131
What this trial is testing

Melatonin in Patients With Multiple Sclerosis (MS).

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Providence Health & Services 30
Not applicableLooking for participantsNCT05962177
What this trial is testing

Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic

Who this might be right for
Multiple Sclerosis
University Hospital, Montpellier 400
Load More Results